景沛，男，1989年生，博士，副研究员。2021年毕业于四川大学，现工作于西南医科大学附属医院药学部，承担临床药学相关的教学和科研工作。四川省纳米药物专委会委员。2025年度入选西南医科大学附属医院优秀中青年人才库。

研究方向：功能性小分子纳米组装体的设计与制备、药物/蛋白质/基因递送的纳米技术及递送机制、机体免疫定向调节等方面的研究。主持四川省科学技术厅、泸州市科学技术和人才工作局等各级各类项目7项。以第一/通讯作者身份在ACS Nano, Biomaterials, Chemical Engineering Journal, Journal of Controlled Release等国内外权威刊物发表SCI检索论文10余篇，其中中国科学院一区9篇，最高影响因子17.1。获发明专利2项。

代表性论文：

1. 丘小娟，黄治伟，冯碧敏，景沛^*，付文广。基于抗氧化策略的纳米材料在肝纤维化治疗中的潜力与挑战。中国医院药学杂志，2025, 45(10), 1192-1197.（北大中文核心）

2. Yujie Wan, Yan Lin, Xie Tan, Lingyi Gong, Fei Lei, Changguang Wang, Xiaoduan Sun, Xingjie Du, Zhirong Zhang, Jun Jiang, Zhongbing Liu, Jingxuan Wang, Xiaoling Zhou, Shuzao Wang, Xiangyu Zhou^*, Pei Jing^*, Zhirong Zhong^*. Injectable hydrogel to deliver bone mesenchymal stem cells preloaded with azithromycin to promotespinal cord repair. ACS Nano, 2024, 18(12), 8934-8951. (中国科学院1区，If: 17.1)

3. Pei Jing, Hongli Luo, Jiangbing Tan, Chunyan Liao, Shiyong Zhang. Natural polyphenol-loaded cross-linked lipoic acid vesicles treat triple-negative breast cancer by cancer cell killing and metastasis inhibition. Materials & Design, 2023, 236, 112461. (中国科学院1区，If: 8.4)

4. Pei Jing, Yuling Luo, Liang Wang, Jiangbing Tan, Yun Chen, Ying Chen, Shiyong Zhang. An oligomeric hyaluronic acid-GX1 molecular target drug with polyvalent targeting to CD44 and VEGF receptors. Biomaterials Advances, 2023, 144, 213217. (中国科学院1区，If: 8.457)

5. Pei Jing, Yuling Luo, Yun Chen, Jiangbing Tan, Chunyan Liao, Shiyong Zhang. Aspirin-loaded cross-linked lipoic acid nanodrug prevents postoperative tumor recurrence by residual cancer cell killing and inflammatory microenvironment improvement. Bioconjugate Chemistry, 2023, 34(2), 366-376. (中国科学院2区，If: 6.069)

6. Xiaosheng Bai, Yan Lin, Lingyi Gong, Junfeng Duan, Xiaoduan Sun, Changguang Wang, Zerong Liu, Jun Jiang, Xiangyu Zhou, Meiling Zhou, Zhirong Zhang, Zhongbing Liu^*, Pei Jing^*, Zhirong Zhong^*. Nanoparticles that target the mitochondria of tumor cells to restore oxygen supply for photodynamic therapy: Design and preclinical validation against breast cancer. Journal of Controlled Release, 2023, 362, 356-370. (中国科学院1区，If: 10.8)

7. Jiangbing Tan¹, Pei Jing¹, Xiao Xiao¹, Yulong Liao, Chunyan Liao, Shiyong Zhang. Cross-linked lipoic acid nanocapsules serve as H₂O₂ amplifier to strengthen the H₂O₂-sensitive prodrug activation. Science China Chemistry, 2023, 66 (9), 2654-2663. (中国科学院1区，If: 9.6)

8. Ting Li, Zhongbing Liu, Jingxuan Wang, Haoming Ye, Yujie Wan, Xingjie Du, Xiaoduan Sun, Meiling Zhou, Yan Lin^*, Pei Jing^*, Zhirong Zhong^*. Nanoformulated metformin enhanced the treatment of spinal cord injury. Chemical Engineering Journal, 2022, 446, 137227. (中国科学院1区，If: 13.273)

9. Liang Wang¹, Pei Jing¹, Juan Tan, Chunyan Liao, Yun Chen, Yunlong Yu, Shiyong Zhang. “One-Stitch” Bioorthogonal Prodrug Activation Based on Cross-Linked Lipoic Acid Nanocapsules. Biomaterials, 2021, 273, 120823. (中国科学院1区，If: 10.317)

10. Pei Jing, Shousong Cao, Shuangli Xiao, Xiaoqin Zhang, Siyun Ke, Famin Ke, Xin Yu, Li Wang, Shurong Wang, Yuling Luo, Zhirong Zhong. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system. Cancer Letters, 2016, 383, 230-242. (中国科学院1区，If: 5.992)

代表性科研项目：

1. 四川省科学技术厅，青年项目，2023NSFSC1691，基于COX调控的纳米胶囊的构建及其激活CD8⁺ T细胞增强三阴性乳腺癌免疫治疗的应用研究，2023-01至2024-12，10万元，结题，主持

2. 泸州市科学技术和人才工作局，应用基础研究，2023LZXNYDJ008，锰介导的聚合多酚纳米药物改善CD8⁺ T细胞耗竭增强三阴性乳腺癌免疫治疗的研究，2023-10至2026-09，8万元，在研，主持

单位：西南医科大学附属医院药学部/西南医科大学药学院临床药学教研室

E-mail：jingpei.09@swmu.edu.cn